Annual Debt To Equity
-0.22
+4.04+94.84%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual debt to equity ratio is -0.22, with the most recent change of +4.04 (+94.84%) on December 31, 2022.
- During the last 3 years, NAVB annual debt to equity has fallen by -0.03 (-15.79%).
- NAVB annual debt to equity is now -114.29% below its all-time high of 1.54, reached on December 31, 2005.
Performance
NAVB Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-0.38
+0.86+69.35%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly debt to equity ratio is -0.38, with the most recent change of +0.86 (+69.35%) on September 30, 2023.
- Over the past year, NAVB quarterly debt to equity has increased by +0.86 (+69.35%).
- NAVB quarterly debt to equity is now -104.58% below its all-time high of 8.29, reached on September 30, 2006.
Performance
NAVB Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
NAVB Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.8% | +69.3% |
| 3 y3 years | -15.8% | +69.3% |
| 5 y5 years | -204.8% | +69.3% |
NAVB Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.8% | -660.0% | +91.1% |
| 5 y | 5-year | -138.6% | +94.8% | -117.7% | +91.1% |
| alltime | all time | -114.3% | +99.3% | -104.6% | +99.3% |
Navidea Biopharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -0.38(-69.4%) |
| Jun 2023 | - | -1.24(+416.7%) |
| Mar 2023 | - | -0.24(-17.2%) |
| Dec 2022 | -0.22(-94.8%) | -0.29(-19.4%) |
| Sep 2022 | - | -0.36(+125.0%) |
| Jun 2022 | - | -0.16(+220.0%) |
| Mar 2022 | - | -0.05(-98.8%) |
| Dec 2021 | -4.26(-847.4%) | -4.26(<-9900.0%) |
| Sep 2021 | - | 0.00(0.0%) |
| Jun 2021 | - | 0.00(-100.0%) |
| Mar 2021 | - | 0.04(-93.0%) |
| Dec 2020 | 0.57(-400.0%) | 0.57(-73.5%) |
| Sep 2020 | - | 2.15(-1364.7%) |
| Jun 2020 | - | -0.17(+70.0%) |
| Mar 2020 | - | -0.10(-47.4%) |
| Dec 2019 | -0.19(-205.6%) | -0.19(<-9900.0%) |
| Sep 2019 | - | 0.00(-100.0%) |
| Jun 2019 | - | 0.04(-111.4%) |
| Mar 2019 | - | -0.35(-294.4%) |
| Dec 2018 | 0.18(-14.3%) | 0.18(-88.8%) |
| Sep 2018 | - | 1.61(+54.8%) |
| Jun 2018 | - | 1.04(+96.2%) |
| Mar 2018 | - | 0.53(+152.4%) |
| Dec 2017 | 0.21(-123.3%) | 0.21(+61.5%) |
| Sep 2017 | - | 0.13(+8.3%) |
| Jun 2017 | - | 0.12(+20.0%) |
| Mar 2017 | - | 0.10(-111.1%) |
| Dec 2016 | -0.90(-19.6%) | -0.90(-7.2%) |
| Sep 2016 | - | -0.97(+2.1%) |
| Jun 2016 | - | -0.95(-10.4%) |
| Mar 2016 | - | -1.06(-5.4%) |
| Dec 2015 | -1.12(-1.8%) | -1.12(-4.3%) |
| Sep 2015 | - | -1.17(-10.7%) |
| Jun 2015 | - | -1.31(+32.3%) |
| Mar 2015 | - | -0.99(-13.2%) |
| Dec 2014 | -1.14(-83.5%) | -1.14(+9.6%) |
| Sep 2014 | - | -1.04(-20.6%) |
| Jun 2014 | - | -1.31(-38.2%) |
| Mar 2014 | - | -2.12(-69.3%) |
| Dec 2013 | -6.90(+0.1%) | -6.90(-320.4%) |
| Sep 2013 | - | 3.13(-121.0%) |
| Jun 2013 | - | -14.90(+211.7%) |
| Mar 2013 | - | -4.78(-30.6%) |
| Dec 2012 | -6.89(-2322.6%) | -6.89(-414.6%) |
| Sep 2012 | - | 2.19(+231.8%) |
| Jun 2012 | - | 0.66(+50.0%) |
| Mar 2012 | - | 0.44(+41.9%) |
| Dec 2011 | 0.31(+1450.0%) | 0.31(>+9900.0%) |
| Sep 2011 | - | 0.00(0.0%) |
| Jun 2011 | - | 0.00(0.0%) |
| Mar 2011 | - | 0.00(-100.0%) |
| Dec 2010 | 0.02(-101.8%) | 0.02(>+9900.0%) |
| Sep 2010 | - | 0.00(0.0%) |
| Jun 2010 | - | 0.00(-100.0%) |
| Mar 2010 | - | -0.99(-10.8%) |
| Dec 2009 | -1.11(-44.5%) | -1.11(+5.7%) |
| Sep 2009 | - | -1.05(+400.0%) |
| Jun 2009 | - | -0.21(-48.8%) |
| Mar 2009 | - | -0.41(-79.5%) |
| Dec 2008 | -2.00 | -2.00(-40.7%) |
| Sep 2008 | - | -3.37(-93.7%) |
| Jun 2008 | - | -53.74(+1709.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -2.97(+115.2%) |
| Dec 2007 | -1.38(-93.9%) | -1.38(-53.1%) |
| Sep 2007 | - | -2.94(-4.2%) |
| Jun 2007 | - | -3.07(-34.3%) |
| Mar 2007 | - | -4.67(-79.3%) |
| Dec 2006 | -22.52(-1562.3%) | -22.52(-371.7%) |
| Sep 2006 | - | 8.29(+212.8%) |
| Jun 2006 | - | 2.65(+35.2%) |
| Mar 2006 | - | 1.96(+27.3%) |
| Dec 2005 | 1.54(+65.6%) | 1.54(+38.7%) |
| Sep 2005 | - | 1.11(+24.7%) |
| Jun 2005 | - | 0.89(+21.9%) |
| Mar 2005 | - | 0.73(-21.5%) |
| Dec 2004 | 0.93(+675.0%) | 0.93(+4550.0%) |
| Sep 2004 | - | 0.02(0.0%) |
| Jun 2004 | - | 0.02(-33.3%) |
| Mar 2004 | - | 0.03(-75.0%) |
| Dec 2003 | 0.12(+140.0%) | 0.12(-7.7%) |
| Sep 2003 | - | 0.13(+18.2%) |
| Jun 2003 | - | 0.11(+266.7%) |
| Mar 2003 | - | 0.03(-40.0%) |
| Dec 2002 | 0.05(+66.7%) | 0.05(-89.8%) |
| Sep 2002 | - | 0.49(+145.0%) |
| Jun 2002 | - | 0.20(+900.0%) |
| Mar 2002 | - | 0.02(-33.3%) |
| Dec 2001 | 0.03(-25.0%) | 0.03(>+9900.0%) |
| Sep 2001 | - | 0.00(-100.0%) |
| Jun 2001 | - | 0.01(-50.0%) |
| Mar 2001 | - | 0.02(-50.0%) |
| Dec 2000 | 0.04(-100.1%) | 0.04(+100.0%) |
| Sep 2000 | - | 0.02(-87.5%) |
| Jun 2000 | - | 0.16(-44.8%) |
| Mar 2000 | - | 0.29(+11.5%) |
| Dec 1999 | -32.63(<-9900.0%) | - |
| Jun 1999 | - | 0.26(+18.2%) |
| Mar 1999 | - | 0.22(-15.4%) |
| Dec 1998 | 0.26(+333.3%) | 0.26(-27.8%) |
| Sep 1998 | - | 0.36(+44.0%) |
| Jun 1998 | - | 0.25(+38.9%) |
| Mar 1998 | - | 0.18(+200.0%) |
| Dec 1997 | 0.06(+200.0%) | 0.06(+20.0%) |
| Sep 1997 | - | 0.05(0.0%) |
| Jun 1997 | - | 0.05(+66.7%) |
| Mar 1997 | - | 0.03(+50.0%) |
| Dec 1996 | 0.02(-75.0%) | 0.02(-50.0%) |
| Sep 1996 | - | 0.04(+100.0%) |
| Jun 1996 | - | 0.02(-50.0%) |
| Mar 1996 | - | 0.04(-50.0%) |
| Dec 1995 | 0.08(0.0%) | 0.08(+14.3%) |
| Sep 1995 | - | 0.07(+133.3%) |
| Jun 1995 | - | 0.03(-50.0%) |
| Mar 1995 | - | 0.06(-25.0%) |
| Dec 1994 | 0.08(+166.7%) | 0.08(0.0%) |
| Sep 1994 | - | 0.08(-11.1%) |
| Jun 1994 | - | 0.09(+125.0%) |
| Mar 1994 | - | 0.04(+33.3%) |
| Dec 1993 | 0.03(+200.0%) | 0.03(+200.0%) |
| Sep 1993 | - | 0.01(>+9900.0%) |
| Jun 1993 | - | 0.00(0.0%) |
| Mar 1993 | - | 0.00(-100.0%) |
| Dec 1992 | 0.01 | 0.01(>+9900.0%) |
| Sep 1992 | - | 0.00 |
FAQ
- What is Navidea Biopharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual debt to equity year-on-year change?
- What is Navidea Biopharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly debt to equity year-on-year change?
What is Navidea Biopharmaceuticals annual debt to equity ratio?
The current annual debt to equity of NAVB is -0.22
What is the all time high annual debt to equity for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual debt to equity ratio is 1.54
What is Navidea Biopharmaceuticals annual debt to equity year-on-year change?
Over the past year, NAVB annual debt to equity ratio has changed by +4.04 (+94.84%)
What is Navidea Biopharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of NAVB is -0.38
What is the all time high quarterly debt to equity for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly debt to equity ratio is 8.29
What is Navidea Biopharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, NAVB quarterly debt to equity ratio has changed by +0.86 (+69.35%)